Stifel Financial Corp Biotechnology

Stifel Financial Corp

$99.8 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMCR Immunocore Holdings PLC	$1.4B	$528,000 0.0% of portfolio	16,830	Q2 2025 Reduced 0.36%
GMAB Genmab A/S	$14.4B	$469,000 0.0% of portfolio	22,748	Q2 2025 Reduced 63.92%
AXSM Axsome Therapeutics, Inc.	$4.51B	$451,000 0.0% of portfolio	4,322	Q2 2025 New
AVXL Anavex Life Sciences Corp.	$840M	$443,000 0.0% of portfolio	48,091	Q2 2025 Added 5.47%
RNA Avidity Biosciences, Inc.	$2.41B	$417,000 0.0% of portfolio	14,716	Q2 2025 Added 0.6%
ZLAB Zai Lab LTD	$3.36B	$393,000 0.0% of portfolio	11,248	Q2 2025 Added 38.22%
IOVA Iovance Biotherapeutics, Inc.	$352M	$388,000 0.0% of portfolio	225,640	Q2 2025 Added 36.9%
ABCL Ab Cellera Biologics Inc.	$1.22B	$384,000 0.0% of portfolio	112,243	Q2 2025 Added 65.88%
FOLD Amicus Therapeutics, Inc.	$1.96B	$352,000 0.0% of portfolio	61,550	Q2 2025 Added 82.43%
NKTX Nkarta, Inc.	$95.4M	$219,000 0.0% of portfolio	132,496	Q2 2025 Added 14.22%
SRPT Sarepta Therapeutics, Inc.	$1.6B	$218,000 0.0% of portfolio	12,765	Q2 2025 Added 33.59%
PHAT Phathom Pharmaceuticals, Inc.	$407M	$196,000 0.0% of portfolio	20,467	Q2 2025 Added 17.64%
BEAM Beam Therapeutics Inc.	$1.19B	$184,000 0.0% of portfolio	10,841	Q2 2025 Reduced 4.52%
TCRX T Scan Therapeutics, Inc.	$31.6M	$168,000 0.0% of portfolio	115,941	Q2 2025 Reduced 0.44%
ALT Altimmune, Inc.	$177M	$160,000 0.0% of portfolio	41,560	Q2 2025 Added 13.86%
ADPT Adaptive Biotechnologies Corp	$1.81B	$148,000 0.0% of portfolio	12,705	Q2 2025 New
CUE Cue Biopharma, Inc.	$28M	$133,000 0.0% of portfolio	196,556	Q2 2025 Reduced 3.45%
SAGE Sage Therapeutics, Inc.	$516M	$118,000 0.0% of portfolio	12,955	Q2 2025 Reduced 2.17%
TRVI Trevi Therapeutics, Inc.	$428M	$112,000 0.0% of portfolio	20,651	Q2 2025 Added 50.57%
RPTX Repare Therapeutics Inc.	$65.4M	$112,000 0.0% of portfolio	80,600	Q1 2025 Reduced 9.94%
GERN Geron Corp	$510M	$106,000 0.0% of portfolio	75,553	Q2 2025 Added 5.4%
CDXS Codexis, Inc.	$187M	$97,000 0.0% of portfolio	39,991	Q2 2025 Reduced 5.06%
CGEN Compugen LTD	$127M	$95,000 0.0% of portfolio	53,455	Q2 2025 Added 2.36%
PGEN Precigen, Inc.	$375M	$79,000 0.0% of portfolio	56,332	Q2 2025 Reduced 1.96%
ABSI Absci Corp	$276M	$66,000 0.0% of portfolio	25,839	Q2 2025 Reduced 2.14%
VYGR Voyager Therapeutics, Inc.	$131M	$62,000 0.0% of portfolio	20,200	Q2 2025 Reduced 0.7%
ARDX Ardelyx, Inc.	$866M	$59,000 0.0% of portfolio	15,150	Q2 2025 Reduced 1.76%
RCKT Rocket Pharmaceuticals, Inc.	$220M	$40,000 0.0% of portfolio	16,350	Q2 2025 Reduced 13.97%
MGNX Macrogenics Inc	$90.3M	$31,000 0.0% of portfolio	26,217	Q2 2025 Reduced 4.22%
CLSD Clearside Biomedical, Inc.	$25.9M	$31,000 0.0% of portfolio	39,944	Q2 2025 Added 66.82%
MRVI Maravai Lifesciences Holdings, Inc.	$354M	$27,000 0.0% of portfolio	11,399	Q2 2025 New
VXRT Vaxart, Inc.	$48.1M	$9,000 0.0% of portfolio	22,090	Q2 2025 Reduced 2.21%
ADAP Adaptimmune Therapeutics PLC	$13.1M	$5,000 0.0% of portfolio	23,007	Q2 2025 Reduced 13.08%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	13,392	Q2 2025 Added 0.16%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.